HER3-DXd shows promising results in the phase II TUXEDO-3 study for patients with limited therapeutic options ...Middle East

The TUXEDO-3 trial is the first study to evaluate the intracranial and extracranial efficacy and safety of a novel anti-cancer drug in patients with breast or lung cancer and active brain metastases, and leptomeningeal disease from solid tumors. These results were presented as an oral...

Read More Details
Finally We wish PressBee provided you with enough information of ( HER3-DXd shows promising results in the phase II TUXEDO-3 study for patients with limited therapeutic options )

Also on site :

• David Hogg draws attacks from both sides as his star rises
• Beloved 'Doctor Who' Star, 42, Returns to the Series in Surprise Twist
• 97 new companies launched in two months, 90% under Syrian leadership